[
  {
    "date": "2023-12-30",
    "symbol": "SNDX",
    "period": "FY",
    "netincomeloss": -209360000,
    "trdarrsecuritiesaggavailamt": 100000,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "SNDX",
    "entityregistrantname": "Syndax Pharmaceuticals, Inc.",
    "entitycentralindexkey": 1395937,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "security12btitle": "Common Stock",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37708",
    "entitytaxidentificationnumber": "32-0162505",
    "entityaddressaddressline1": "35 Gatehouse Drive",
    "entityaddressaddressline2": "Building D",
    "entityaddressaddressline3": "Floor 3",
    "entityaddresscityortown": "Waltham",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2451,
    "cityareacode": 781,
    "localphonenumber": "419-1400",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "securityexchangename": "NASDAQ",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "Yes",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "New York, New York",
    "auditorfirmid": 34,
    "cashandcashequivalentsatcarryingvalue": 295394000,
    "shortterminvestments": 275304000,
    "depositsassetscurrent": 6885000,
    "collaborationreceivable": 2200000,
    "prepaidexpenseandotherassetscurrent": 3293000,
    "assetscurrent": 580876000,
    "longterminvestments": 29829000,
    "propertyplantandequipmentnet": 8000,
    "operatingleaserightofuseasset": 1487000,
    "restrictedcashnoncurrent": 217000,
    "otherassetsnoncurrent": 463000,
    "assets": 612880000,
    "accountspayablecurrent": 9961000,
    "collaborationpayablecurrent": 7232000,
    "accruedliabilitiesandotherliabilities": 39856000,
    "operatingleaseliabilitycurrent": 1035000,
    "currentportionofcapitallease": 12000,
    "liabilitiescurrent": 58096000,
    "operatingleaseliabilitynoncurrent": 578000,
    "capitalleaselesscurrentportion": 10000,
    "liabilitiesnoncurrent": 588000,
    "liabilities": 58684000,
    "commonstockvalue": 8000,
    "additionalpaidincapitalcommonstock": 1456370000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 218000,
    "retainedearningsaccumulateddeficit": -902400000,
    "stockholdersequity": 554196000,
    "liabilitiesandstockholdersequity": 612880000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesoutstanding": 84826632,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2023#LicenseMember",
    "researchanddevelopmentexpense": 163032000,
    "sellinggeneralandadministrativeexpense": 66922000,
    "operatingexpenses": 229954000,
    "operatingincomeloss": -229954000,
    "interestexpense": 208000,
    "investmentincomeinterest": 21163000,
    "othernonoperatingincomeexpense": -361000,
    "nonoperatingincomeexpense": 20594000,
    "netincomelossavailabletocommonstockholdersbasic": -209360000,
    "earningspersharebasic": -2.98,
    "earningspersharediluted": -2.98,
    "weightedaveragenumberofsharesoutstandingbasic": 70370519,
    "weightedaveragenumberofdilutedsharesoutstanding": 70370519,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 1024000,
    "comprehensiveincomenetoftax": -208336000,
    "sharesoutstanding": 84826632,
    "stockissuedduringperiodvalueatthemarketofferingnet": 42139000,
    "stockissuedduringperiodsharesatthemarketofferingnet": 2719744,
    "stockissuedduringperiodvaluedirectoffering": 1000,
    "stockissuedduringperiodsharesdirectoffering": 12432431,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 34797,
    "prefundedwarrantexerciseshares": 857131,
    "stockissuedduringperiodvaluenewissues": 14000000,
    "stockissuedduringperiodsharesnewissues": 2719744,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 30951000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 9102,
    "employeewithholdingsespp": 910000,
    "stockissuedduringperiodvaluestockoptionsexercised": 5128000,
    "stockissuedduringperiodsharesstockoptionsexercised": 662042,
    "stockissuedduringperiodvalueatthemarketofferingexpenses": 1086000,
    "stockissuedduringperiodvalueofferingexpenses": 14044000,
    "profitloss": -209360000,
    "depreciationandrelatedadjustment": 12000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 14803000,
    "noncashoperatingleaseexpense": 739000,
    "sharebasedcompensation": 30951000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -676000,
    "increasedecreaseincollaborationreceivable": 10706000,
    "increasedecreaseinaccountspayable": 5611000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 14867000,
    "netcashprovidedbyusedinoperatingactivities": -160601000,
    "paymentstoacquireshortterminvestments": 354606000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 472215000,
    "netcashprovidedbyusedininvestingactivities": 117609000,
    "proceedsfromissuanceofcommonstock": 215955000,
    "proceedsfromstockplans": 910000,
    "proceedsfromstockoptionsexercised": 5128000,
    "netcashprovidedbyusedinfinancingactivities": 264132000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 221140000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 295611000,
    "restrictedcashcurrent": 217000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P3Y",
    "percentageofincometaxcontingencyrealized": 0.5,
    "collaborationexpenseduetocounterparty": 9500000,
    "operatingleaseweightedaverageremainingleaseterm1": "P14M",
    "operatingleaseliability": 1600000,
    "operatingleaseweightedaveragediscountratepercent": 0.14,
    "operatingleaseexpense": 743000,
    "operatingleasepayments": 924000,
    "lesseeoperatingleaseoptiontoextend": "On August 17, 2021, the Company signed a 36-month extension to the lease for the Waltham, MA office with aggregate payments of $1.6 million, with a lease commencement date of March 1, 2022.",
    "financeleaseliabilitypaymentsdue": 25864000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1196000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 606000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1802000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 189000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 10685,
    "propertyplantandequipmentgross": 84000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 411000,
    "depreciation": 12000000,
    "cashandcashequivalentsfairvaluedisclosure": 295394000,
    "assetsfairvaluedisclosure": 600527000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 160657000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 149000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 40000,
    "availableforsalesecuritiesdebtsecurities": 160806000,
    "prepaidinsurance": 807000,
    "interestreceivablecurrent": 1227000,
    "prepaidsubscriptions": 769000,
    "prepaidstateandlocaltaxes": 264000,
    "prepaidrent": 163000,
    "otherprepaidexpensecurrent": 63000,
    "accruedclinicalcostscurrent": 16346000,
    "employeerelatedliabilitiescurrent": 11172000,
    "accruedprofessionalfeescurrent": 1450000,
    "accruedmilestonecosts": 10000000,
    "otheraccruedliabilitiescurrent": 888000,
    "commonstockcapitalsharesreservedforfutureissuance": 285714,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1750000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 74800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3800691,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 140000,
    "employeeservicesharebasedcompensationrecognizedstockoptions": 258000,
    "allocatedsharebasedcompensationexpense": 14147000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 16.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 9500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "one – year anniversary date of the related grant or ii) 25% on each anniversary for 4 years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 308550,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 126000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 9102,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 24.94,
    "definedcontributionplanemployerdiscretionarycontributionamount": 1300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.7513,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0365,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 10684858,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 435468,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5468638,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 17.78,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 23.75,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 8.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 23.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 14.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 17.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 55091000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 43160000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 55091000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 519436,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 4800,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 22.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 24.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 13.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 20.36,
    "currentstateandlocaltaxexpensebenefit": 300000,
    "valuationallowancedeferredtaxassetchangeinamount": 72900000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 136400000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 63500000,
    "deferredtaxassetsoperatinglosscarryforwardsexpirationperiod": 2026,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 8900000,
    "deferredtaxassetsresearchcreditsexpirationperiod": 2024,
    "unrecognizedtaxbenefitsperiodincreasedecrease": 100000,
    "deferredtaxassetsliabilitiesnet": 79600000,
    "deferredtaxassetstaxdeferredexpense": 53700000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.132,
    "effectiveincometaxratereconciliationtaxcredits": -0.015,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.01,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.349,
    "effectiveincometaxratecontinuingoperations": -0.002,
    "deferredtaxassetsoperatinglosscarryforwards": 32664000,
    "deferredtaxassetsinprocessresearchanddevelopment": 11765000,
    "deferredtaxassetscapitalizedstartupandothercosts": 68859000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 79562000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 10276000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2795000,
    "deferredtaxassetsother": 36000,
    "deferredtaxassetsgross": 205957000,
    "deferredtaxassetsvaluationallowance": 205957000,
    "unrecognizedtaxbenefits": 143000,
    "debtissuancecostsincurredduringnoncashorpartialnoncashtransaction": 250000
  },
  {
    "date": "2022-12-30",
    "symbol": "SNDX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "SNDX",
    "entityregistrantname": "Syndax Pharmaceuticals, Inc.",
    "entitycentralindexkey": 1395937,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "security12btitle": "Common Stock",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37708",
    "entitytaxidentificationnumber": "32-0162505",
    "entityaddressaddressline1": "35 Gatehouse Drive",
    "entityaddressaddressline2": "Building D",
    "entityaddressaddressline3": "Floor 3",
    "entityaddresscityortown": "Waltham",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2451,
    "cityareacode": 781,
    "localphonenumber": "419-1400",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "securityexchangename": "NASDAQ",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "Yes",
    "icfrauditorattestationflag": "true",
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "New York, New York",
    "auditorfirmid": 34,
    "cashandcashequivalentsatcarryingvalue": 74356000,
    "shortterminvestments": 401446000,
    "depositsassetscurrent": 8595000,
    "collaborationreceivable": 3474000,
    "prepaidexpenseandotherassetscurrent": 1915000,
    "assetscurrent": 489786000,
    "longterminvestments": 5469000,
    "propertyplantandequipmentnet": 20000,
    "operatingleaserightofuseasset": 1039000,
    "restrictedcashnoncurrent": 115000,
    "otherassetsnoncurrent": 807000,
    "assets": 497236000,
    "accountspayablecurrent": 4350000,
    "accruedliabilitiesandotherliabilities": 24276000,
    "operatingleaseliabilitycurrent": 434000,
    "currentportionofcapitallease": 5000,
    "liabilitiescurrent": 29065000,
    "operatingleaseliabilitynoncurrent": 709000,
    "capitalleaselesscurrentportion": 13000,
    "liabilitiesnoncurrent": 722000,
    "liabilities": 29787000,
    "commonstockvalue": 7000,
    "additionalpaidincapitalcommonstock": 1161288000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -806000,
    "retainedearningsaccumulateddeficit": -693040000,
    "stockholdersequity": 467449000,
    "liabilitiesandstockholdersequity": 497236000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesoutstanding": 68111385,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2022#LicenseMember",
    "researchanddevelopmentexpense": 118499000,
    "generalandadministrativeexpense": 33258000,
    "operatingexpenses": 151757000,
    "operatingincomeloss": -151757000,
    "interestexpense": 3137000,
    "investmentincomeinterest": 5872000,
    "othernonoperatingincomeexpense": -316000,
    "nonoperatingincomeexpense": 2419000,
    "netincomeloss": -149338000,
    "netincomelossavailabletocommonstockholdersbasic": -149338000,
    "earningspersharebasic": -2.46,
    "earningspersharediluted": -2.46,
    "weightedaveragenumberofsharesoutstandingbasic": 60760906,
    "weightedaveragenumberofdilutedsharesoutstanding": 60760906,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -851000,
    "comprehensiveincomenetoftax": -150189000,
    "sharesoutstanding": 68111385,
    "stockissuedduringperiodvalueatthemarketofferingnet": 19425000,
    "stockissuedduringperiodsharesatthemarketofferingnet": 1111111,
    "stockissuedduringperiodvaluedirectoffering": 1000,
    "stockissuedduringperiodsharesdirectoffering": 7840909,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 28999,
    "prefundedwarrantexerciseshares": 2832151,
    "stockissuedduringperiodvaluenewissues": 10500000,
    "stockissuedduringperiodsharesnewissues": 1111111,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 16019000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 38749,
    "employeewithholdingsespp": 401000,
    "stockissuedduringperiodvaluestockoptionsexercised": 11459000,
    "stockissuedduringperiodsharesstockoptionsexercised": 1276361,
    "stockissuedduringperiodvalueofferingexpenses": 600000,
    "profitloss": -149338000,
    "depreciationandrelatedadjustment": 33000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 3382000,
    "noncashoperatingleaseexpense": 421000,
    "paidinkindinterestandinterestreversal": 1103000,
    "derivativegainlossonderivativenet": 187000,
    "sharebasedcompensation": 16019000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2972000,
    "increasedecreaseincollaborationreceivable": -3474000,
    "increasedecreaseinaccountspayable": -1319000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 9421000,
    "netcashprovidedbyusedinoperatingactivities": -133675000,
    "proceedsfromsaleofmachineryandequipment": 225000,
    "paymentstoacquireshortterminvestments": 495346000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 308933000,
    "netcashprovidedbyusedininvestingactivities": -186188000,
    "proceedsfromissuanceofcommonstock": 161965000,
    "paymentsforproceedsfromdepositonloan": 20996000,
    "proceedsfromstockplans": 401000,
    "proceedsfromstockoptionsexercised": 11459000,
    "netcashprovidedbyusedinfinancingactivities": 172254000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -147609000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 74471000,
    "restrictedcashcurrent": 115000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P3Y",
    "percentageofincometaxcontingencyrealized": 0.5,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "operatingleaseweightedaverageremainingleaseterm1": "P26M",
    "operatingleaseliability": 1100000,
    "operatingleaseweightedaveragediscountratepercent": 0.14,
    "operatingleaseexpense": 440000,
    "operatingleasepayments": 567000,
    "lesseeoperatingleaseoptiontoextend": "On August 17, 2021, the Company signed a 36-month extension to the lease for the Waltham, Massachusetts office with aggregate payments of $1.6 million, with a lease commencement date of March 1, 2022.",
    "financeleaseliabilitypaymentsdue": 22441,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 567000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 585000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryeartwo": 199000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1351000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 208000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7982,
    "developmentandregulaotrymilestonesexpenses": 2000000,
    "propertyplantandequipmentgross": 84000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 399000,
    "depreciation": 33000000,
    "cashandcashequivalentsfairvaluedisclosure": 74356000,
    "assetsfairvaluedisclosure": 481271000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilitychangeinfairvalue": 187000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 321630000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 205000,
    "availableforsalesecuritiesdebtsecurities": 321425000,
    "prepaidinsurance": 692000,
    "interestreceivablecurrent": 583000,
    "prepaidsubscriptions": 446000,
    "otherprepaidexpensecurrent": 194000,
    "accruedclinicalcostscurrent": 14375000,
    "employeerelatedliabilitiescurrent": 5945000,
    "accruedprofessionalfeescurrent": 1352000,
    "accruedmilestonecosts": 2000000,
    "otheraccruedliabilitiescurrent": 604000,
    "commonstockcapitalsharesreservedforfutureissuance": 1142856,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1750000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 43000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3020850,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 140000,
    "employeeservicesharebasedcompensationrecognizedstockoptions": 6000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 140000,
    "allocatedsharebasedcompensationexpense": 6016000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 12.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 17000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "one – year anniversary date of the related grant or ii) 25% on each anniversary for 4 years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 131205,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 705000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 38750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 15.79,
    "definedcontributionplanemployerdiscretionarycontributionamount": 712000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.7787,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0252,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7981677,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 684326,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4313997,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 18.39,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 8.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 17.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 88016000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 61851000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 88016000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 224788,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 18.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 15.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 17.61,
    "lineofcreditfacilitymaximumborrowingcapacity": 80000000,
    "lineofcreditfacilityinterestratedescription": "Borrowings under the Amended Loan Agreement bore interest at an annual interest rate from the greater of (y) 9.25% or (z) 6.00% plus the Wall Street Journal prime rate",
    "debtinstrumentinterestratestatedpercentage": 0.0925,
    "debtinstrumentbasisspreadonvariablerate1": 0.06,
    "percentageofprepaymentpremiumofprincipalamountoutstandinginfirstyear": 0.02,
    "percentageofprepaymentpremiumofprincipalamountoutstandinginsecondyear": 0.015,
    "percentageofprepaymentpremiumofprincipalamountoutstandingthereafter": 0.01,
    "percentageofendoftermchargetofuturedraws": 0.0499,
    "prepaymentfee": 400000,
    "interestexpensedebt": 2100000,
    "valuationallowancedeferredtaxassetchangeinamount": 35900000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 99600000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 42800000,
    "deferredtaxassetsoperatinglosscarryforwardsexpirationperiod": 2026,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 5700000,
    "deferredtaxassetsresearchcreditsexpirationperiod": 2022,
    "unrecognizedtaxbenefitsperiodincreasedecrease": 100000,
    "deferredtaxassetsliabilitiesnet": 48900000,
    "deferredtaxassetstaxdeferredexpense": 22200000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.025,
    "effectiveincometaxratereconciliationtaxcredits": -0.01,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.241,
    "returntoprovisiontrueup": -0.002,
    "deferredtaxassetsoperatinglosscarryforwards": 23650000,
    "deferredtaxassetsinprocessresearchanddevelopment": 8124000,
    "deferredtaxassetscapitalizedstartupandothercosts": 45374000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 48917000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 5004000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1985000,
    "deferredtaxassetsother": 27000,
    "deferredtaxassetsgross": 133081000,
    "deferredtaxassetsvaluationallowance": 133081000,
    "unrecognizedtaxbenefits": 143000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 20000,
    "interestpaidnet": 2059000,
    "debtissuancecostsincurredduringnoncashorpartialnoncashtransaction": 131000
  },
  {
    "date": "2021-12-30",
    "symbol": "SNDX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "SNDX",
    "entityregistrantname": "Syndax Pharmaceuticals, Inc.",
    "entitycentralindexkey": 1395937,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "security12btitle": "Common Stock",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37708",
    "entitytaxidentificationnumber": "32-0162505",
    "entityaddressaddressline1": "35 Gatehouse Drive",
    "entityaddressaddressline2": "Building D",
    "entityaddressaddressline3": "Floor 3",
    "entityaddresscityortown": "Waltham",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2451,
    "cityareacode": 781,
    "localphonenumber": "419-1400",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "securityexchangename": "The Nasdaq Stock Market, LLC",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "Yes",
    "icfrauditorattestationflag": "true",
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "New York, New York",
    "auditorfirmid": 34,
    "cashandcashequivalentsatcarryingvalue": 221965000,
    "restrictedcash": 115000,
    "shortterminvestments": 217971000,
    "prepaidexpenseandotherassetscurrent": 8345000,
    "assetscurrent": 448396000,
    "propertyplantandequipmentnet": 278000,
    "operatingleaserightofuseasset": 983000,
    "assets": 449657000,
    "accountspayablecurrent": 5669000,
    "accruedliabilitiesandotherliabilities": 14466000,
    "operatingleaseliabilitycurrent": 361000,
    "derivativeliabilitiescurrent": 187000,
    "liabilitiescurrent": 20683000,
    "operatingleaseliabilitynoncurrent": 711000,
    "longtermloanspayable": 19895000,
    "liabilitiesnoncurrent": 20606000,
    "liabilities": 41289000,
    "commonstockvalue": 6000,
    "additionalpaidincapitalcommonstock": 952019000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 45000,
    "retainedearningsaccumulateddeficit": -543702000,
    "stockholdersequity": -543702000,
    "liabilitiesandstockholdersequity": 449657000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 139709000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2021-01-31#LicenseMember",
    "researchanddevelopmentexpense": 88248000,
    "generalandadministrativeexpense": 25241000,
    "operatingexpenses": 113489000,
    "operatingincomeloss": 26220000,
    "interestexpense": 1899000,
    "investmentincomeinterest": 403000,
    "othernonoperatingincomeexpense": 202000,
    "nonoperatingincomeexpense": -1294000,
    "netincomeloss": 24926000,
    "netincomelossavailabletocommonstockholdersbasic": 24926000,
    "earningspersharebasic": 0.48,
    "earningspersharediluted": 0.46,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 49000,
    "comprehensiveincomenetoftax": 24975000,
    "sharesoutstanding": "null",
    "stockissuedduringperiodvalueatthemarketofferingnet": 5131000,
    "stockissuedduringperiodsharesatthemarketofferingnet": 277629,
    "stockissuedduringperiodvaluedirectoffering": 81206000,
    "stockissuedduringperiodsharesdirectoffering": "null",
    "stockissuedduringperiodsharesprefundedcommonstockwarrantsfromdirectoffering": 725784,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 26878,
    "stockissuedduringperiodvaluenewissues": 24848000,
    "stockissuedduringperiodsharesnewissues": 277629,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 13317000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 5500,
    "adjustmenttoadditionalpaidincapitalincometaxeffectfromsharebasedcompensationnet": 367000,
    "stockissuedduringperiodvaluestockoptionsexercised": 6336000,
    "stockissuedduringperiodsharesstockoptionsexercised": 842424,
    "stockissuedduringperiodvalueofferingexpenses": 5332000,
    "stockissuedduringperiodvalueprefundedcommonstockwarrantofferingexpenses": 159000,
    "profitloss": 24926000,
    "depreciationandrelatedadjustment": 43000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -644000,
    "noncashoperatingleaseexpense": 413000,
    "paidinkindinterestandinterestreversal": -225000,
    "derivativegainlossonderivativenet": 389000,
    "sharebasedcompensation": 13317000,
    "othernoncashincomeexpense": 1000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1394000,
    "increasedecreaseinaccountspayable": 2161000,
    "increasedecreaseincontractwithcustomerliability": -13133000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 2769000,
    "netcashprovidedbyusedinoperatingactivities": 29131000,
    "paymentstoacquirepropertyplantandequipment": 129000,
    "paymentstoacquireshortterminvestments": 294719000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 253975000,
    "netcashprovidedbyusedininvestingactivities": -40873000,
    "proceedsfromissuanceofcommonstock": 5100000,
    "proceedsfromstockplans": 367000,
    "proceedsfromstockoptionsexercised": 6336000,
    "netcashprovidedbyusedinfinancingactivities": 118464000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 106722000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 222080000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "five years",
    "percentageofincometaxcontingencyrealized": 0.5,
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2021",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "upfrontpaymentsreceived": 117000000,
    "sharesissuedpricepershare": 24.62,
    "revenuefromcontractwithcustomermilestonemethodfactors": "In accordance with the terms of the license agreement",
    "revenueremainingperformanceobligation": 17300000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionyear1": 2029,
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "operatingleaseweightedaverageremainingleaseterm1": 8,
    "operatingleaseliability": 1100000,
    "operatingleaseweightedaveragediscountratepercent": 0.14,
    "operatingleaseexpense": 413000,
    "operatingleasepayments": 544000,
    "lesseeoperatingleaseoptiontoextend": "In February 2021, the Company signed an 18-month extension to the lease for the New York office, with aggregate payments of $270,000, with a lease commencement date of March 1, 2021.",
    "financeleaseliabilitypaymentsdue": 1000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 473000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 376000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearthree": 454000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1303000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 231000,
    "incrementalcommonsharesattributabletosharebasedpaymentarrangements": 1558000,
    "classofwarrantorrightissued": "null",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 18,
    "numberofprefundedwarrantsexchangedforcommonstock": 250000,
    "numberofprefundedwarrantscashlessexchangedforcommonstock": 475784,
    "classofwarrantorrightoutstanding": "null",
    "accruedmilestoneexpenses": 2000000,
    "contractualobligation": 24700000,
    "remainingcontractualobligation": 3200000,
    "contractualobligationsterm": "one year",
    "accruedcontractualobligation": 3000000,
    "propertyplantandequipmentgross": 721000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 443000,
    "depreciation": 43000,
    "cashandcashequivalentsfairvaluedisclosure": 125148000,
    "assetsfairvaluedisclosure": 343119000,
    "derivativeliabilities": 187000,
    "liabilitiesfairvaluedisclosure": 187000,
    "derivativeliabilitymeasurementinput": 0.595,
    "derivativeliabilityexpectedtimingofterminationright": "P9M",
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 187000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalueadditions": 576000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilitychangeinfairvalue": 389000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 343074000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 70000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 25000,
    "availableforsalesecuritiesdebtsecurities": 343119000,
    "depositsassetscurrent": 6894000,
    "prepaidinsurance": 642000,
    "interestreceivablecurrent": 429000,
    "otherprepaidexpensecurrent": 380000,
    "accruedclinicalcostscurrent": 7760000,
    "employeerelatedliabilitiescurrent": 4342000,
    "accruedprofessionalfeescurrent": 662000,
    "otheraccruedliabilitiescurrent": 1702000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": "null",
    "warrantsexercisedperiod": 2020,
    "maximumperiodallowedtoincreasebeneficialownershiplimitationafternotice": 61,
    "exerciseofwarrantslowerlimitafterexerciseaspercentageofcommonstock": 0.0999,
    "maximumbeneficialownershiplimitationpercentage": 0.1999,
    "fairvalueofwarrants": 3400000,
    "warrantsandrightsoutstandingmeasurementinput": 0.891,
    "warrantsandrightsoutstandingterm": 1.4,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 24800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "employeeservicesharebasedcompensationrecognizedstockoptions": 257000,
    "allocatedsharebasedcompensationexpense": 175000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 14.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 10100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 119333,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 60000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 5500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 21.19,
    "definedcontributionplanemployerdiscretionarycontributionamount": 444000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8584,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0067,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 210697,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 20.61,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 7.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 15.57,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 68609000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 54012000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 68609000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 132333,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 21.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 11.17,
    "lineofcreditfacilityinterestratedescription": "decreased the annual interest rate from the greater of (w) 9.85% or (x) 5.10% plus the Wall Street Journal prime rate to the greater of (y) 9.25% or (z) 6.00% plus the Wall Street Journal prime rate",
    "debtinstrumentcarryingamount": "null",
    "lineofcreditfacilityfrequencyofpaymentandpaymentterms": "extended the expiration of the period in which interest-only payments on borrowings under the Loan Agreement are required from October 1, 2021 to January 1, 2023, which is further extendable to December 31, 2023 upon the partial or full draw of Tranche 2 (the “Interest-Only Period”)",
    "interestexpensedebt": 1900000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": "null",
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": "null",
    "amortizedlossesreacquireddebtnoncurrent": 17591,
    "unamortizeddebtissuanceexpense": 122927,
    "loanspayable": "null",
    "valuationallowancedeferredtaxassetchangeinamount": -4800000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 25000000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 34600000,
    "deferredtaxassetsoperatinglosscarryforwardsexpirationperiod": 2026,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2500000,
    "deferredtaxassetsresearchcreditsexpirationperiod": 2022,
    "unrecognizedtaxbenefitsperiodincreasedecrease": 200000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.028999999999999998,
    "effectiveincometaxratereconciliationtaxcredits": 0.05,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.005,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.192,
    "effectiveincometaxratereconciliationotheradjustments": 0.008,
    "deferredtaxassetsoperatinglosscarryforwards": 17642000,
    "deferredtaxassetsinprocessresearchanddevelopment": 6113000,
    "deferredtaxassetscapitalizedstartupandothercosts": 34898000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 31365000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 6277000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 845000,
    "deferredtaxassetsother": 10000,
    "deferredtaxassetsgross": 97150000,
    "deferredtaxassetsvaluationallowance": 97150000,
    "unrecognizedtaxbenefits": 163000,
    "interestpaidnet": 1997000,
    "debtissuancecostsincurredduringnoncashorpartialnoncashtransaction": 134000
  },
  {
    "date": "2020-12-30",
    "symbol": "SNDX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2020",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "SNDX",
    "entityregistrantname": "Syndax Pharmaceuticals, Inc.",
    "entitycentralindexkey": 1395937,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "security12btitle": "Common Stock",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37708",
    "entitytaxidentificationnumber": "32-0162505",
    "entityaddressaddressline1": "35 Gatehouse Drive",
    "entityaddressaddressline2": "Building D",
    "entityaddressaddressline3": "Floor 3",
    "entityaddresscityortown": "Waltham",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2451,
    "cityareacode": 781,
    "localphonenumber": "419-1400",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "securityexchangename": "The Nasdaq Stock Market, LLC",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "Yes",
    "icfrauditorattestationflag": "false",
    "cashandcashequivalentsatcarryingvalue": 115243000,
    "restrictedcash": 115000,
    "shortterminvestments": 177822000,
    "prepaidexpenseandotherassetscurrent": 5684000,
    "assetscurrent": 298864000,
    "propertyplantandequipmentnet": 192000,
    "operatingleaserightofuseasset": 290000,
    "otherassetsnoncurrent": 1267000,
    "assets": 300613000,
    "accountspayablecurrent": 3508000,
    "accruedliabilitiesandotherliabilities": 11246000,
    "contractwithcustomerliabilitycurrent": 1517000,
    "operatingleaseliabilitycurrent": 316000,
    "loanspayablecurrent": 2285000,
    "liabilitiescurrent": 18872000,
    "contractwithcustomerliabilitynoncurrent": 11617000,
    "operatingleaseliabilitynoncurrent": 101000,
    "longtermloanspayable": 17834000,
    "otherliabilitiesnoncurrent": 1000,
    "liabilitiesnoncurrent": 29553000,
    "liabilities": 48425000,
    "commonstockvalue": 5000,
    "additionalpaidincapitalcommonstock": 820815000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -4000,
    "retainedearningsaccumulateddeficit": -568628000,
    "stockholdersequity": -568628000,
    "liabilitiesandstockholdersequity": 300613000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 1517000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseMember",
    "researchanddevelopmentexpense": 50435000,
    "generalandadministrativeexpense": 22505000,
    "operatingexpenses": 72940000,
    "operatingincomeloss": -71423000,
    "interestexpense": 2200000,
    "investmentincomeinterest": 841000,
    "othernonoperatingincomeexpense": -219000,
    "nonoperatingincomeexpense": -1735000,
    "netincomeloss": -73158000,
    "netincomelossavailabletocommonstockholdersbasic": -77064000,
    "earningspersharebasicanddiluted": -1.87,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -4000,
    "comprehensiveincomenetoftax": -73162000,
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 6633000,
    "stockissuedduringperiodsharesstockoptionsexercised": 755166,
    "stockissuedduringperiodvaluedirectoffering": 134981000,
    "stockissuedduringperiodsharesdirectoffering": "null",
    "stockissuedduringperiodvalueprefundedcommonstockwarrantsfromdirectoffering": 10665000,
    "stockissuedduringperiodsharesprefundedcommonstockwarrantsfromdirectoffering": "null",
    "adjustmentstoadditionalpaidincapitaldeemeddividendfromrepricingwarrants": 3906000,
    "adjustmentstoadditionalpaidincapitalrepricingwarrant": 3906000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 33706,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 9057000,
    "stockissuedduringperiodsharesexerciseofwarrants": "null",
    "adjustmenttoadditionalpaidincapitalincometaxeffectfromsharebasedcompensationnet": 345000,
    "stockissuedduringperiodvalueofferingexpenses": 8770000,
    "stockissuedduringperiodvalueprefundedcommonstockwarrantofferingexpenses": 41000,
    "profitloss": -73158000,
    "depreciationandrelatedadjustment": 89000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 130000,
    "noncashoperatingleaseexpense": 426000,
    "paidinkindinterest": 389000,
    "sharebasedcompensation": 9057000,
    "othernoncashincomeexpense": -1000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 4314000,
    "increasedecreaseinaccountspayable": -2670000,
    "increasedecreaseincontractwithcustomerliability": -1517000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 567000,
    "netcashprovidedbyusedinoperatingactivities": -71260000,
    "paymentstoacquireshortterminvestments": 278937000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 136407000,
    "netcashprovidedbyusedininvestingactivities": -142530000,
    "proceedsfromissuanceofcommonstock": 34866000,
    "proceedsfromdebtnetofissuancecosts": 19730000,
    "proceedsfromstockplans": 345000,
    "proceedsfromstockoptionsexercised": 6633000,
    "proceedsfrompaymentsforotherfinancingactivities": 1000,
    "netcashprovidedbyusedinfinancingactivities": 304424000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 90634000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 115358000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "five years",
    "percentageofincometaxcontingencyrealized": 0.5,
    "revenuefromcontractwithcustomermilestonemethodfactors": "In accordance with the terms of the license agreement",
    "revenueremainingperformanceobligation": 17300000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionyear1": 2029,
    "contractwithcustomerliability": 13100000,
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "operatingleaseweightedaverageremainingleaseterm1": 2,
    "operatingleaseliability": 400000,
    "operatingleaseweightedaveragediscountratepercent": 0.14,
    "operatingleaseexpense": 425000,
    "operatingleasepayments": 597000,
    "lesseeoperatingleaseoptiontoextend": "In February 2021, the Company signed an 18-month extension to the lease for the New York office, with aggregate payments of $270,000, with a lease commencement date of March 1, 2021.",
    "financeleaseliabilitypaymentsdue": 5000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 394000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 59000,
    "lesseeoperatingleaseliabilitypaymentsdue": 453000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 36000,
    "dividends": 3906000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 16382,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 18,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": "null",
    "numberofprefundedwarrantsexchangedforcommonstock": "null",
    "classofwarrantorrightoutstanding": "null",
    "contractualobligation": 24700000,
    "remainingcontractualobligation": 3200000,
    "contractualobligationsterm": "one year",
    "accruedcontractualobligation": 1600000,
    "propertyplantandequipmentgross": 591000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 399000,
    "cashandcashequivalentsfairvaluedisclosure": 5000000,
    "assetsfairvaluedisclosure": 182819000,
    "availableforsalesecuritiesdebtsecurities": 182819000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 182823000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 15000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 19000,
    "depositsassetscurrent": 4683000,
    "prepaidinsurance": 427000,
    "otherprepaidexpensecurrent": 317000,
    "interestreceivablecurrent": 175000,
    "supplies": 58000,
    "reimbursablecosts": 24000,
    "accruedclinicalcostscurrent": 7132000,
    "employeerelatedliabilitiescurrent": 3213000,
    "accruedprofessionalfeescurrent": 373000,
    "otheraccruedliabilitiescurrent": 528000,
    "saleofstockpricepershare": 7.82,
    "classofwarrantorrightterm": 90,
    "weightedaverageexercisepriceofwarrants": 12,
    "adjustedweightedaverageexercisepriceofwarrants": 6,
    "maximumperiodallowedtoincreasebeneficialownershiplimitationafternotice": 61,
    "exerciseofwarrantslowerlimitafterexerciseaspercentageofcommonstock": 0.0999,
    "maximumbeneficialownershiplimitationpercentage": 0.1999,
    "fairvalueofwarrants": 3400000,
    "warrantsandrightsoutstandingmeasurementinput": 0.891,
    "warrantsandrightsoutstandingterm": 1.4,
    "numberofwarrantsexercisedincashlessexercise": "null",
    "commonstockcapitalsharesreservedforfutureissuance": 576283,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 13900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 194000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 388669,
    "employeeservicesharebasedcompensationrecognizedstockoptions": 207000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 18500,
    "allocatedsharebasedcompensationexpense": 203000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 7100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 10.48,
    "definedcontributionplanemployerdiscretionarycontributionamount": 250000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y11M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8159000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.012,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 557735,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 11.91,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 8.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 7.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 9.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 81940000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 53828000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 81668000,
    "lineofcreditfacilityinterestratedescription": "Borrowings under the Loan Agreement bear interest at an annual rate equal to the greater of (i) 9.85% or (ii) 5.10% plus the Wall Street Journal prime rate.",
    "debtinstrumentinterestrateeffectivepercentage": 0.0985,
    "lineofcreditfacilityminimumcashcovenantwaived": 12500000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 2285000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 9727000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 7988000,
    "debtinstrumentcarryingamount": 20000000,
    "amortizedlossesreacquireddebtnoncurrent": 306000,
    "unamortizeddebtissuanceexpense": 187000,
    "loanspayable": 20119000,
    "valuationallowancedeferredtaxassetchangeinamount": 17500000,
    "valuationallowancemethodologiesandassumptions": "The Company has provided a valuation allowance for the full amount of the net deferred tax assets as the realization of the deferred tax assets is not determined to be more likely than not. The valuation allowance increased by $17.5 million and $12.8 million in 2020 and 2019, respectively, due to the increase in deferred tax assets, primarily due to net operating loss carryforwards and capitalized research and development costs.",
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 96100000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 41000000,
    "deferredtaxassetsoperatinglosscarryforwardsexpirationperiod": 2024,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2000000,
    "deferredtaxassetsresearchcreditsexpirationperiod": 2022,
    "unrecognizedtaxbenefitsperiodincreasedecrease": 200000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.018000000000000002,
    "effectiveincometaxratereconciliationtaxcredits": 0.009000000000000001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.237,
    "deferredtaxassetsoperatinglosscarryforwards": 22794000,
    "deferredtaxassetsinprocessresearchanddevelopment": 4856000,
    "deferredtaxassetscapitalizedstartupandothercosts": 28854000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 35632000,
    "deferredtaxassetsdeferredincome": 2989000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 5117000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1657000,
    "deferredtaxassetsother": 29000,
    "deferredtaxassetsgross": 101928000,
    "deferredtaxassetsvaluationallowance": 101928000,
    "unrecognizedtaxbenefits": 163000,
    "interestpaidnet": 1631000,
    "debtissuancecostsincurredduringnoncashorpartialnoncashtransaction": 43000
  },
  {
    "date": "2019-12-30",
    "symbol": "SNDX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "SNDX",
    "entityregistrantname": "Syndax Pharmaceuticals Inc",
    "entitycentralindexkey": 1395937,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "security12btitle": "Common Stock",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37708",
    "entitytaxidentificationnumber": "32-0162505",
    "entityaddressaddressline1": "35 Gatehouse Drive",
    "entityaddressaddressline2": "Building D",
    "entityaddressaddressline3": "Floor 3",
    "entityaddresscityortown": "Waltham",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2451,
    "cityareacode": 781,
    "localphonenumber": "419-1400",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "securityexchangename": "NASDAQ",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "cashandcashequivalentsatcarryingvalue": 24609000,
    "shortterminvestments": 35166000,
    "prepaidexpenseandotherassetscurrent": 2556000,
    "assetscurrent": 62331000,
    "propertyplantandequipmentnet": 281000,
    "operatingleaserightofuseasset": 716000,
    "otherassetsnoncurrent": 197000,
    "assets": 63525000,
    "accountspayablecurrent": 6178000,
    "accruedliabilitiesandotherliabilities": 10195000,
    "contractwithcustomerliabilitycurrent": 1517000,
    "operatingleaseliabilitycurrent": 478000,
    "liabilitiescurrent": 18368000,
    "contractwithcustomerliabilitynoncurrent": 13133000,
    "operatingleaseliabilitynoncurrent": 419000,
    "otherliabilitiesnoncurrent": 5000,
    "liabilitiesnoncurrent": 13557000,
    "liabilities": 31925000,
    "commonstockvalue": 3000,
    "additionalpaidincapitalcommonstock": 527067000,
    "retainedearningsaccumulateddeficit": -495470000,
    "stockholdersequity": -495470000,
    "liabilitiesandstockholdersequity": 63525000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesoutstanding": 27140484,
    "revenuefromcontractwithcustomerexcludingassessedtax": 1517000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseMember",
    "researchanddevelopmentexpense": 42994000,
    "generalandadministrativeexpense": 16062000,
    "operatingexpenses": 59056000,
    "operatingincomeloss": -57539000,
    "interestincomeexpensenonoperatingnet": 1571000,
    "othernonoperatingincomeexpense": -79000,
    "nonoperatingincomeexpense": 1492000,
    "netincomeloss": -56047000,
    "netincomelossavailabletocommonstockholdersbasic": -56047000,
    "earningspersharebasicanddiluted": -1.84,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 30490783,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 25000,
    "comprehensiveincomenetoftax": -56022000,
    "sharesoutstanding": 27140484,
    "stockissuedduringperiodvaluestockoptionsexercised": 178000,
    "stockissuedduringperiodsharesstockoptionsexercised": 25857,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 6005000,
    "stockissuedduringperiodvalueatthemarketofferingnet": 830000,
    "stockissuedduringperiodsharesatthemarketofferingnet": 140819,
    "stockissuedduringperiodvaluedirectoffering": 10902000,
    "stockissuedduringperiodsharesdirectoffering": 2095039,
    "stockissuedduringperiodvalueprefundedcommonstockwarrantsfromdirectoffering": 13032000,
    "stockissuedduringperiodvaluecommonstockwarrantwithdirectoffering": 3446000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 42818,
    "adjustmenttoadditionalpaidincapitalincometaxeffectfromsharebasedcompensationnet": 182000,
    "stockissuedduringperiodvalueatthemarketofferingexpenses": 34000,
    "profitloss": -56047000,
    "depreciation": 92000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 780000,
    "noncashoperatingleaseexpense": 359000,
    "sharebasedcompensation": 6005000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 52000,
    "increasedecreaseinaccountspayable": 4739000,
    "increasedecreaseincontractwithcustomerliability": -1517000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -3411000,
    "netcashprovidedbyusedinoperatingactivities": -50612000,
    "paymentstoacquireshortterminvestments": 104018000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 116799000,
    "netcashprovidedbyusedininvestingactivities": 12781000,
    "proceedsfromissuanceofcommonstock": 27380000,
    "proceedsfromstockplans": 182000,
    "proceedsfromstockoptionsexercised": 178000,
    "netcashprovidedbyusedinfinancingactivities": 28570000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -9261000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 24724000,
    "restrictedcash": 115000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentestimatedusefullives": "five years",
    "costsrelatedtocostsharingcollaborations": 2000000,
    "increasedecreaseinresearchanddevelopmentexpense": 1000000,
    "percentageofincometaxcontingencyrealized": 0.5,
    "revenuefromcontractwithcustomermilestonemethodfactors": "In accordance with the terms of the license agreement",
    "revenueremainingperformanceobligation": 17300000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionyear1": 2029,
    "contractwithcustomerliability": 14700000,
    "operatingleaseliability": 897000,
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "operatingleaseweightedaverageremainingleaseterm1": "P14M",
    "operatingleaseweightedaveragediscountratepercent": 0.14,
    "operatingleaseexpense": 447000,
    "operatingleasepayments": 566000,
    "financeleaseliabilitypaymentsdue": 9000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 585000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 394000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 59000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1038000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 141000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 15223,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 18,
    "contractualobligation": 24500000,
    "remainingcontractualobligation": 6700000,
    "contractualobligationsterm": "P2Y",
    "propertyplantandequipmentgross": 591000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 310000,
    "cashandcashequivalentsfairvaluedisclosure": 1200000,
    "assetsfairvaluedisclosure": 36336000,
    "availableforsalesecuritiesdebtsecurities": 36336000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 36336000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 5000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 5000,
    "depositsassetscurrent": 1297000,
    "supplies": 166000,
    "interestreceivablecurrent": 116000,
    "reimbursablecosts": 416000,
    "prepaidinsurance": 214000,
    "otherprepaidexpensecurrent": 347000,
    "accruedprofessionalfeescurrent": 403000,
    "employeerelatedliabilitiescurrent": 2800000,
    "accruedclinicalcostscurrent": 6726000,
    "otheraccruedliabilitiescurrent": 266000,
    "saleofstockpricepershare": 7.82,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 4595039,
    "classofwarrantorrightterm": "P90D",
    "weightedaverageexercisepriceofwarrants": 12,
    "adjustedweightedaverageexercisepriceofwarrants": 6,
    "maximumperiodallowedtoincreasebeneficialownershiplimitationafternotice": "P61D",
    "exerciseofwarrantslowerlimitafterexerciseaspercentageofcommonstock": 0.0999,
    "maximumbeneficialownershiplimitationpercentage": 0.1999,
    "fairvalueofwarrants": 3400000,
    "warrantsandrightsoutstandingmeasurementinput": 0.891,
    "warrantsandrightsoutstandingterm": "P1Y4M24D",
    "commonstockcapitalsharesreservedforfutureissuance": 586554,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1750000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 9400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1964025,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 5655008,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 134140,
    "employeeservicesharebasedcompensationrecognizedstockoptions": 181000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 583000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 9000,
    "allocatedsharebasedcompensationexpense": 113000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 119000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y11M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.7695,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0229,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6057011,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3620626,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 8.5,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.99,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 6.86,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 9.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 8.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 6306000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 3114000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 5373000,
    "valuationallowancedeferredtaxassetchangeinamount": 12800000,
    "valuationallowancemethodologiesandassumptions": "The Company has provided a valuation allowance for the full amount of the net deferred tax assets as the realization of the deferred tax assets is not determined to be more likely than not. The valuation allowance increased by $12.8 million and $17.2 million in 2019 and 2018, respectively, due to the increase in deferred tax assets, primarily due to net operating loss carryforwards and capitalized research and development costs.",
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 68000000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 33100000,
    "deferredtaxassetsoperatinglosscarryforwardsexpirationperiod": 2025,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1600000,
    "deferredtaxassetsresearchcreditsexpirationperiod": 2021,
    "unrecognizedtaxbenefitsperiodincreasedecrease": 200000,
    "deferredtaxassetsoperatinglosscarryforwards": 16410000,
    "deferredtaxassetsinprocessresearchanddevelopment": 4156000,
    "deferredtaxassetscapitalizedstartupandcostsresearchanddevelopmentcostsnet": 55452000,
    "deferredtaxassetsdeferredincome": 3334000,
    "deferredtaxliabilitiesdepreciationandamortizationofcapitalizedcost": -13000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 828000,
    "deferredtaxassetsother": 4223000,
    "deferredtaxassetsgross": 84416000,
    "deferredtaxassetsvaluationallowance": 84416000,
    "unrecognizedtaxbenefits": 163000
  }
]